ASX · ACW.AX
Actinogen Medical Limited
A$0.04-A$0.00 (-2.33%)
Actinogen Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 41.67% below the high.
Loading market information…
ASX · SDI.AX · AUD
Stock price, dividends, earnings
Quote as of Jun 25, 2026, 10:19 PM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
SDI Limited’s quoted price sits in the upper half of its reported 52-week range, 0.21% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SDI Limited’s forward annual dividend is A$0.04 per share, paid semi-annual. The forward yield is 2.72% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow SDI Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SDI Limited, an Australian company, specializes in the development, manufacturing, and global distribution of diverse dental materials. Their core business encompasses dental restorative solutions, tooth whitening systems, and a wide array of other dental supplies. The product portfolio includes bonding agents, dental alloys, cements, composite resins, etching gels, glass ionomer cements, dental sealants, and treatments for tooth sensitivity, in addition to their whitening range. The company also supplies essential dental equipment and related accessories. SDI's offerings reach an international market through a network of distributors, authorized dealers, and direct sales to dental practitioners. Founded in 1972, the firm's main office is situated in Bayswater, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.04-A$0.00 (-2.33%)
Actinogen Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 41.67% below the high.
A$0.11-A$0.01 (-4.35%)
Alcidion Group Limited’s quoted price sits in the lower half of its reported 52-week range, 24.14% below the high.
A$2.74A$0.00 (0.0%)
Vita Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 5.52% below the high.
A$0.36+A$0.03 (+9.09%)
Recce Pharmaceuticals Ltd’s quoted price sits in the lower half of its reported 52-week range, 50.68% below the high.
A$0.29-A$0.04 (-10.77%)
Island Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 53.97% below the high.
A$0.05+A$0.00 (+3.92%)
Arovella Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
A$0.27+A$0.01 (+1.92%)
Alterity Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 66.24% below the high.
A$0.25-A$0.01 (-3.85%)
Trajan Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 68.55% below the high.
